Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.
Fujii H, Tsuchiya M, Watanabe D, Otsuka R, Hirate D, Takahashi K, Go M, Kudo T, Shimomura K, Ando Y, Tani S, Takahashi T, Hayashi K, Chin M, Matsunami N, Takahashi M, Hasegawa A, Uchida T, Hashimoto H, Kubo A, Matsuhashi N, Suzuki A, Nishimura J, Inui N, Iihara H. Fujii H, et al. Among authors: kudo t. Support Care Cancer. 2024 Apr 17;32(5):291. doi: 10.1007/s00520-024-08498-z. Support Care Cancer. 2024. PMID: 38630197
Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
Sueda T, Kudo T, Sakai D, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Ezoe S, Matsumoto K, Doki Y, Mori M, Satoh T. Sueda T, et al. Among authors: kudo t. Cancer Chemother Pharmacol. 2014 Dec;74(6):1321-4. doi: 10.1007/s00280-014-2620-8. Epub 2014 Nov 6. Cancer Chemother Pharmacol. 2014. PMID: 25374410
Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
Nishimura J, Satoh T, Fukunaga M, Takemoto H, Nakata K, Ide Y, Fukuzaki T, Kudo T, Miyake Y, Yasui M, Morita S, Sakai D, Uemura M, Hata T, Takemasa I, Mizushima T, Ohno Y, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M; Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO). Nishimura J, et al. Among authors: kudo t. Eur J Cancer. 2015 Jul;51(10):1274-82. doi: 10.1016/j.ejca.2015.03.024. Epub 2015 Apr 24. Eur J Cancer. 2015. PMID: 25922233 Clinical Trial.
[Recurrence of Jejunal Carcinoma in the Ileum and Ovary - A Case Report].
Ohara N, Haraguchi N, Kudo T, Takahashi H, Nishimura J, Hata T, Matsuda C, Satoh T, Mizushima T, Yamamoto H, Doki Y, Mori M. Ohara N, et al. Among authors: kudo t. Gan To Kagaku Ryoho. 2016 Nov;43(12):1803-1805. Gan To Kagaku Ryoho. 2016. PMID: 28133137 Japanese.
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy.
Mizushima T, Fukunaga M, Sueda T, Ikeda M, Kato T, Kim HM, Kudo T, Murata K, Nishimura J, Hata T, Matsuda C, Yamamoto H, Doki Y, Mori M. Mizushima T, et al. Among authors: kudo t. Cancer Chemother Pharmacol. 2017 Jul;80(1):81-90. doi: 10.1007/s00280-017-3336-3. Epub 2017 May 16. Cancer Chemother Pharmacol. 2017. PMID: 28510802 Clinical Trial.
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Danno K, Hata T, Tamai K, Fujie Y, Ide Y, Kim HM, Ohnishi T, Morita S, Yoshioka S, Kudo T, Nishimura J, Matsuda C, Akamatsu H, Mizushima T, Nezu R, Doki Y, Mori M; Multi-Center Clinical Study Group of Osaka; Colorectal Cancer Treatment Group (MCSGO). Danno K, et al. Among authors: kudo t. Cancer Chemother Pharmacol. 2017 Oct;80(4):777-785. doi: 10.1007/s00280-017-3419-1. Epub 2017 Aug 19. Cancer Chemother Pharmacol. 2017. PMID: 28825216 Clinical Trial.
A phase II study of the safety of olanzapine for oxaliplatin based chemotherapy in coloraectal patients.
Nishimura J, Hasegawa A, Kudo T, Otsuka T, Yasui M, Matsuda C, Haraguchi N, Ushigome H, Nakai N, Abe T, Hara H, Shinno N, Asukai K, Hasegawa S, Yamada D, Sugimura K, Yamamoto K, Wada H, Takahashi H, Omori T, Miyata H, Ohue M. Nishimura J, et al. Among authors: kudo t. Sci Rep. 2021 Feb 25;11(1):4547. doi: 10.1038/s41598-021-84225-6. Sci Rep. 2021. PMID: 33633328 Free PMC article. Clinical Trial.
2,823 results